These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19919014)

  • 1. [Modeling of the polycystic ovary syndrome].
    Chebotareva IuIu; Ovsiannikov VG
    Patol Fiziol Eksp Ter; 2009; (3):29-31. PubMed ID: 19919014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of cold stress on polycystic ovary syndrome in rat: before and during modeling.
    Zangeneh FZ; Abdollahi A; Tavassoli P; Naghizadeh MM
    Arch Gynecol Obstet; 2011 Sep; 284(3):651-7. PubMed ID: 20949356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal window in which exposure to estradiol permanently modifies ovarian function causing polycystic ovary morphology in rats.
    Cruz G; Barra R; González D; Sotomayor-Zárate R; Lara HE
    Fertil Steril; 2012 Nov; 98(5):1283-90. PubMed ID: 22854013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic ovary syndrome--searching for an animal model.
    Szukiewicz D; Uilenbroek JT
    J Med; 1998; 29(5-6):259-75. PubMed ID: 10503163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of testosterone on cancellous bone, marrow adipocytes, and ovarian phenotype in a young female rat model of polycystic ovary syndrome.
    Tamura N; Kurabayashi T; Nagata H; Matsushita H; Yahata T; Tanaka K
    Fertil Steril; 2005 Oct; 84 Suppl 2():1277-84. PubMed ID: 16210021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of opioid system and its interaction with sympathetic nervous system in the processing of polycystic ovary syndrome modeling in rat.
    Zangeneh FZ; Mohammadi A; Ejtemaeimehr Sh; Naghizadeh MM; Fatemeh A
    Arch Gynecol Obstet; 2011 Apr; 283(4):885-92. PubMed ID: 21132313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation of vasoactive intestinal polypeptide in ovarian steroids production during the rat estrous cycle and in the development of estradiol valerate-induced polycystic ovary.
    Parra C; Fiedler JL; Luna SL; Greiner M; Padmanabhan V; Lara HE
    Reproduction; 2007 Jan; 133(1):147-54. PubMed ID: 17244741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid fails to induce polycystic ovary syndrome in female rats.
    Lagace DC; Nachtigal MW
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun; 27(4):587-94. PubMed ID: 12787843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome.
    Mannerås L; Cajander S; Holmäng A; Seleskovic Z; Lystig T; Lönn M; Stener-Victorin E
    Endocrinology; 2007 Aug; 148(8):3781-91. PubMed ID: 17495003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of pituitary cell populations in rats with induced polycystic ovaries.
    Francou M; Durdos M; Salvetti NR; Baravalle C; Rey F; Ortega HH
    Cells Tissues Organs; 2008; 188(3):310-9. PubMed ID: 18376105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and maintenance of a polycystic condition in ovaries autotransplanted under the kidney capsule.
    Desjardins GC; Brawer JR
    Anat Rec; 1989 Oct; 225(2):118-23. PubMed ID: 2817425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenergic innervation and steroidogenic activity of cystic porcine ovaries.
    Dzienis A; Majewski M; Wojtkiewicz J; Piskuła M; Jana B
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():114-6. PubMed ID: 15638392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of ovarian sympathetic nerves in polycystic ovary syndrome.
    Lara HE; Ferruz JL; Luza S; Bustamante DA; Borges Y; Ojeda SR
    Endocrinology; 1993 Dec; 133(6):2690-5. PubMed ID: 7902268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycystic ovary syndrome (PCOS)-like phenotypes in the d-galactose-induced aging mouse model.
    Park JH; Choi TS
    Biochem Biophys Res Commun; 2012 Nov; 427(4):701-4. PubMed ID: 23022527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in sympathetic nerve activity of the mammalian ovary during a normal estrous cycle and in polycystic ovary syndrome: Studies on norepinephrine release.
    Lara HE; Dorfman M; Venegas M; Luza SM; Luna SL; Mayerhofer A; Guimaraes MA; Rosa E Silva AA; Ramírez VD
    Microsc Res Tech; 2002 Dec; 59(6):495-502. PubMed ID: 12467025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of glycemic and oxidative/antioxidative status in the estradiol valerate-induced PCOS model of rats.
    Dikmen A; Ergenoglu AM; Yeniel AO; Dilsiz OY; Ercan G; Yilmaz H
    Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):55-9. PubMed ID: 22071112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Exposure to High-Sucrose Diet Leads to Deteriorated Ovarian Health.
    de Melo GB; Soares JF; Costa TCL; Benevides ROA; Vale CC; Paes AMA; Gaspar RS
    Front Endocrinol (Lausanne); 2021; 12():656831. PubMed ID: 33953699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycystic ovary syndrome induced by exposure to testosterone propionate and effects of sympathectomy on the persistence of the syndrome.
    Morales-Ledesma L; Díaz Ramos JA; Trujillo Hernández A
    Reprod Biol Endocrinol; 2017 Jul; 15(1):50. PubMed ID: 28693534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occasional transsynaptic viral labeling in the central nervous system from the polycystic ovary induced by estradiol valerate.
    Gerendai I; Wiesel O; Tóth IE; Boldogköi Z; Hornyák A; Halász B
    Microsc Res Tech; 2005 Mar; 66(4):186-92. PubMed ID: 15889426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effects of isoflavone-aglycone fraction from soybean (
    Alivandi Farkhad S; Khazali H
    Gynecol Endocrinol; 2019 Dec; 35(12):1078-1083. PubMed ID: 31185755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.